These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20534148)

  • 1. Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study.
    Lloyd-Smith E; Wood E; Zhang R; Tyndall MW; Sheps S; Montaner JS; Kerr T
    BMC Public Health; 2010 Jun; 10():327. PubMed ID: 20534148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DETERMINANTS OF CUTANEOUS INJECTION-RELATED INFECTIONS AMONG INJECTION DRUG USERS AT AN EMERGENCY DEPARTMENT.
    Lloyd-Smith E; Tyndall M; Zhang R; Grafstein E; Sheps S; Wood E; Montaner J; Kerr T
    Open Infect Dis J; 2012 Jan; 6():. PubMed ID: 24339842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.
    Lloyd-Smith E; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    BMC Public Health; 2008 Dec; 8():405. PubMed ID: 19068133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of cutaneous injection-related infection care at a supervised injecting facility.
    Lloyd-Smith E; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Ann Epidemiol; 2009 Jun; 19(6):404-9. PubMed ID: 19364660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
    PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent incarceration linked to cutaneous injection-related infections among active injection drug users in a Canadian setting.
    Milloy MJ; Wood E; Lloyd-Smith E; Grafstein E; Tyndall M; Montaner J; Kerr T
    J Community Health; 2010 Dec; 35(6):660-6. PubMed ID: 20364303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital utilization and costs in a cohort of injection drug users.
    Palepu A; Tyndall MW; Leon H; Muller J; O'Shaughnessy MV; Schechter MT; Anis AH
    CMAJ; 2001 Aug; 165(4):415-20. PubMed ID: 11531049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
    Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
    Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to health and social services for IDU: the impact of a medically supervised injection facility.
    Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
    Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.
    Ti L; Buxton J; Harrison S; Dobrer S; Montaner J; Wood E; Kerr T
    J Hosp Med; 2015 May; 10(5):301-6. PubMed ID: 25754871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of Vancouver's supervised injection facility.
    Bayoumi AM; Zaric GS
    CMAJ; 2008 Nov; 179(11):1143-51. PubMed ID: 19015565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection drug use cessation and use of North America's first medically supervised safer injecting facility.
    DeBeck K; Kerr T; Bird L; Zhang R; Marsh D; Tyndall M; Montaner J; Wood E
    Drug Alcohol Depend; 2011 Jan; 113(2-3):172-6. PubMed ID: 20800976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
    Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis.
    Kimmel SD; Walley AY; Li Y; Linas BP; Lodi S; Bernson D; Weiss RD; Samet JH; Larochelle MR
    JAMA Netw Open; 2020 Oct; 3(10):e2016228. PubMed ID: 33052402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility.
    DeBeck K; Wood E; Zhang R; Tyndall M; Montaner J; Kerr T
    Subst Abuse Treat Prev Policy; 2008 May; 3():11. PubMed ID: 18462491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with hospitalization for blood-borne viral infections among treatment-seeking illicit drug users.
    Onyeka IN; Olubamwo O; Beynon CM; Ronkainen K; Föhr J; Tiihonen J; Tuomola P; Tasa N; Kauhanen J
    J Subst Abuse Treat; 2015 Jun; 53():71-7. PubMed ID: 25736625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.